AlphaMark Advisors’s Parnell Pharmaceuticals Holdings Ltd PARN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-400
| Closed | – | – | 599 |
|
|
2020
Q2 | $0 | Hold |
400
| – | – | ﹤0.01% | 658 |
|
|
2020
Q1 | $0 | Hold |
400
| – | – | ﹤0.01% | 646 |
|
|
2019
Q4 | $0 | Hold |
400
| – | – | ﹤0.01% | 538 |
|
|
2019
Q3 | $0 | Hold |
400
| – | – | ﹤0.01% | 542 |
|
|
2019
Q2 | $0 | Hold |
400
| – | – | ﹤0.01% | 547 |
|
|
2019
Q1 | $0 | Buy |
+400
| New | – | ﹤0.01% | 536 |
|
|
2018
Q4 | – | Sell |
-400
| Closed | – | – | 547 |
|
|
2018
Q3 | $0 | Hold |
400
| – | – | ﹤0.01% | 563 |
|
|
2018
Q2 | $0 | Buy |
+400
| New | – | ﹤0.01% | 561 |
|
|
2018
Q1 | – | Sell |
-400
| Closed | – | – | 549 |
|
|
2017
Q4 | $0 | Hold |
400
| – | – | ﹤0.01% | 539 |
|
|
2017
Q3 | $0 | Hold |
400
| – | – | ﹤0.01% | 574 |
|
|
2017
Q2 | $0 | Hold |
400
| – | – | ﹤0.01% | 573 |
|
|
2017
Q1 | $0 | Hold |
400
| – | – | ﹤0.01% | 537 |
|
|
2016
Q4 | $0 | Hold |
400
| – | – | ﹤0.01% | 489 |
|
|
2016
Q3 | $1K | Hold |
400
| – | – | ﹤0.01% | 338 |
|
|
2016
Q2 | $1K | Sell |
400
-400
| -50% | -$735 | ﹤0.01% | 331 |
|
|
2016
Q1 | $2K | Hold |
800
| – | – | ﹤0.01% | 301 |
|
|
2015
Q4 | $3K | Buy |
+800
| New | +$3.04K | ﹤0.01% | 282 |
|
AlphaMark Advisors's PARN Position: Q3 2020 in Review
AlphaMark Advisors sold out of Parnell Pharmaceuticals Holdings Ltd (PARN) in Q3 2020, closing a stake of 400 shares.
AlphaMark Advisors first reported a position in PARN in Q4 2015 and held it in 17 quarters. The position peaked at $3K in Q4 2015. 0 funds tracked by Wall St. Rank hold PARN as of Q3 2020.
- AlphaMark Advisors reported no remaining Parnell Pharmaceuticals Holdings Ltd position as of Q3 2020 after selling out during the quarter.
- AlphaMark Advisors sold 400 Parnell Pharmaceuticals Holdings Ltd shares in Q3 2020.
- AlphaMark Advisors first reported a position in Parnell Pharmaceuticals Holdings Ltd in Q4 2015 and held it in 17 quarters.
- AlphaMark Advisors's Parnell Pharmaceuticals Holdings Ltd position peaked at $3K in Q4 2015.
- 0 funds tracked by Wall St. Rank held Parnell Pharmaceuticals Holdings Ltd as of Q3 2020.
Based on AlphaMark Advisors's 13F filing for Q3 2020, filed 6 Nov 2020.